Archive for MHRA Updates
Class 2 Medicines Recall: Crescent Pharma Limited, Paroxetine 40mg Film Coated Tablets, EL(22)A/19
Source: MHRA 27.4.22 Crescent Pharma Limited are recalling Paroxetine 40mg Film Coated Tablets as a precautionary measure. MDR number MDR 136-03/22 Company name Crescent Pharma Limited Product name Paroxetine 40mg...
Annual flu letter for 2022-2023
Source: UK Health Security Agency, NHS England, and Department of Health and Social Care 22.4.22 The annual flu letter describes the national flu immunisation programme and outlines which groups are eligible for...
Pregabalin (Lyrica): findings of safety study on risks during pregnancy
Source: MHRA 19.4.22 Advice for healthcare professionals: an observational study of more than 2,700 pregnancies exposed to pregabalin has shown use in the first trimester to be associated with a...
Consultation on a new Code of Practice for the Expert Advisory Committees
Source: MHRA & Commission on Human Medicines We are consulting on a set of proposals to improve and strengthen the Code of Practice for experts who provide advice on which...
Class 4 Medicines Defect Information: Pfizer Limited, Depo-Medrone with Lidocaine 40 mg/mL (1 mL and 2 mL vials – single vial preparations), EL (22)A/18
Source: MHRA 21.4.22 Pfizer Limited have informed the MHRA that an outdated version of the Patient Information Leaflet (PIL) has been included in the packaging of the specific batches mentioned...
Upcoming Spring Tutorials!
Please note, it is not essential to attend course parts in order, as they have been designed to be stand-alone sessions and the full learning benefit will still be achieved. Non-members...
Class 2 Medicines Recall: USV UK Limited, Olopatadine USV 1mg/ml Eye Drops, Solution, EL(22)A/17
Source: MHRA / Gov.uk 11.4.22 USV UK Limited are recalling specific batches of products as a precautionary measure due to out of specification results for impurities during routine stability testing....
Class 2 Medicines Recall: USV UK Limited, Olopatadine USV 1mg/ml Eye Drops, Solution, EL(22)A/17
Source: MHRA / Gov.uk – 11 April 2022 USV UK Limited are recalling specific batches of products as a precautionary measure due to out of specification results for impurities during...
Upcoming Spring Tutorials- Secure your places!
Please note, it is not essential to attend course parts in order, as they have been designed to be stand-alone sessions and the full learning benefit will still be achieved. Non-members...
National Patient Safety Alert: Philips Health Systems V60, V60 Plus and V680 ventilators: potential unexpected shutdown leading to complete loss of ventilation (NatPSA/2022/002/MHRA)
Source: MHRA / Gov.uk 29.3.22 Philips Health Systems informed have identified an important safety issue due to potential unexpected shutdowns of all of their V60 and V60 Plus non-invasive ventilators....
Class 2 Medicines Recall: Pfizer Limited, Accuretic 10/12.5 mg film-coated tablets, EL (22)A/16
Source: MHRA / Gov.uk 23.3.22 Pfizer Ltd are recalling batch number DD4842 as a precautionary measure due to the identification of a nitrosamine above the acceptable limit. Company name Pfizer...
Class 4 Medicines Defect Information: Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder and solvent for suspension for injection, EL (22)A/15
Source: MHRA / Gov.uk 17.3.22 Brancaster Pharma Limited have notified us of an issue relating to the label of the Water for Injections (solvent) packaged in each finished product pack....
